At C2C Consultancy, Greg Geissinger leverages his deep understanding of regulatory frameworks and clinical trial strategies to advise clients on efficient, compliant, and successful commercialization efforts. He specializes in guiding medical technologies through rigorous clinical and regulatory processes, streamlining pathways to market and accelerating product approvals. Greg has successfully navigated complex global regulatory landscapes, consistently ensuring compliance with international quality standards and facilitating timely market entry. His proven expertise spans regulatory strategy, clinical trial management, and quality assurance, developed through senior leadership roles at Aqua Medical, Attune Neurosciences, Acutus Medical, ReShape Medical, Boston Scientific, Covidien Neurovascular, and Dexcom.